Repositori institucional URV
| URV's Author/s: | Lejeune, Marylène Marie |
| Author, as appears in the article.: | Godinez, Jose M; Tous, Sara; Baixeras, Nuria; Moreno-Crespi, Judith; Alejo, Maria; Lejeune, Marylene; Bravo, Ignacio G; Bosch, F Xavier; de Sanjose, Silvia |
| Author's mail: | marylenemarie.lejeune@urv.cat |
| Author identifier: | 0000-0001-8441-9404 |
| Journal publication year: | 2011 |
| Publication Type: | Journal Publications |
| ISSN: | 17509378 |
| APA: | Godinez, Jose M; Tous, Sara; Baixeras, Nuria; Moreno-Crespi, Judith; Alejo, Maria; Lejeune, Marylene; Bravo, Ignacio G; Bosch, F Xavier; de Sanjose, S (2011). Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array. Infectious Agents And Cancer, 6(1), 23-. DOI: 10.1186/1750-9378-6-23 |
| Paper original source: | Infectious Agents And Cancer. 6 (1): 23- |
| Abstract: | Certain Human Papillomaviruses (HPVs) are the infectious agents involved in cervical cancer development. Detection of HPVs DNA is part of the cervical cancer screening protocols and HPVs genotyping has been proposed for its inclusion in these preventive programs. The aim of this study was to evaluate three novel genotyping tests, namely Qiagen LQ, RH and PS, in clinical samples with and without abnormalities. For this, 305 cervical samples were processed and the results of the evaluated techniques were compared with those obtained in the HPVs diagnostic process in our lab, by using HC2 and Linear Array (LA) technologies.The concordances and kappa statistics (k) for each technique compared with HC2 were 98.69% (k = 0.94) for LQ, 98.03% (k = 0.91) for RH and 91.80% (k = 0.82) for PS. There was a very good agreement in HPVs type-specific concordance for the most prevalent types HPV16 (kappa range = 0.83-0.90), HPV18 (k.r.= 0.74-0.80) and HPV45 (k.r.= 0.82-0.90).The three tests showed an overall good concordance for HPVs detection when compared with HR-HC2 system. LQ and RH rendered lower detection rate for multiple infections than LA genotyping. However, our understanding of the clinical significance of multiple HPVs infections is still incomplete and therefore the relevance of the lower ability to detect multiple infections needs to be evaluated. |
| Article's DOI: | 10.1186/1750-9378-6-23 |
| Link to the original source: | https://infectagentscancer.biomedcentral.com/articles/10.1186/1750-9378-6-23 |
| Paper version: | info:eu-repo/semantics/publishedVersion |
| licence for use: | https://creativecommons.org/licenses/by/3.0/es/ |
| Department: | Ciències Mèdiques Bàsiques |
| Licence document URL: | https://repositori.urv.cat/ca/proteccio-de-dades/ |
| Thematic Areas: | Saúde coletiva Química Oncology Medicina iii Medicina ii Medicina i Interdisciplinar Infectious diseases Immunology Farmacia Epidemiology Enfermagem Ciências biológicas iii Ciências biológicas i Ciências ambientais Cancer research Biotecnología Biodiversidade |
| Keywords: | Papillomaviruses Hpv Genotyping Cervical cancer screening |
| Entity: | Universitat Rovira i Virgili |
| Record's date: | 2024-10-12 |
| Journal volume: | 6 |
| Search your record at: |   |
| File | Description | Format | |
|---|---|---|---|
| DocumentPrincipal | DocumentPrincipal | application/pdf |
© 2011 Universitat Rovira i Virgili